Name: Opus Genetics, Inc. (IRD) Financial Statements
Creator: FinSpry

Opus Genetics Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

Opus Genetics, Inc. income statement - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Revenue & Gross Profit
Revenue	10.99	19.05	39.85	0.59	0.00
Cost of Revenue	26.85	17.65	14.36	15.17	6.65
Gross Profit	-15.86	1.40	25.50	-14.58	-6.65
Operating Expenses
Research & Development	26.85	17.65	14.36	15.17	0.00
Selling, General & Administrative	18.22	11.96	7.27	8.12	2.82
Operating Expenses	18.22	29.61	7.27	8.12	2.82
Operating Income	-34.07	-10.56	18.23	-22.71	-9.47
Other Income/Expense
Interest Income	2.00	1.80	0.16	0.00	0.00
Interest Expense	0.00	1.33	-0.01	0.00	-6.85
Other Income/Expense	2.56	1.92	-0.01	-33.83	-1.48
Income
Income Before Tax	-57.53	-9.97	18.20	-56.69	-24.62
Income Tax Expense	0.00	0.01	0.32	0.00	0.00
Net Income	-57.53	-9.99	17.89	-56.69	-24.62
Net Income - Continuous Operations	-57.53	-9.99	17.89	-56.69	0.00
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00	0.00
EBITDA	-34.06	-8.64	18.23	-22.70	-9.46
EBIT	-34.07	-8.65	18.23	-22.71	-9.47
Depreciation & Amortization	0.01	0.01	0.00	0.00	0.01
Earnings Per Share
Basic EPS	-2.00	-	1.00	-4.00	-5.00
Diluted EPS	-2.00	-	1.00	-4.00	-5.00
Basic Shares Outstanding	26.72	21.59	19.93	14.85	4.66
Diluted Shares Outstanding	26.72	21.59	20.60	14.85	4.66